|
Immune Checkpoint Inhibitor Maintenance Clinical Trials
1 actively recruiting trial
Also known as: Atezolizumab, Nivolumab, Pembrolizumab
Top Sponsors
- Fundación Santa Fe de Bogota1
Indications
- Metastatic Gastric Cancer1
- Gastric Adenocarcinoma1
- Stomach Neoplasms1
- Cancer1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.